TCMD (Tactile Systems Technology) DeferredTaxAndRevenue: $0.0 Mil (As of Mar. 2026)


TCMD Tactile Systems Technology Inc TCMD
74 GF Score
Price $29.85
GF Value $18.74
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Tactile Systems Technology DeferredTaxAndRevenue?

Tactile Systems Technology TCMD -2.64% 74 DeferredTaxAndRevenue is $0.0 Mil as of Mar. 2026. GuruFocus rates TCMD with a GF Score™ of 74/100 and a GF Value™ of $18.74 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Tactile Systems Technology's current deferred tax and revenue for the quarter that ended in Mar. 2026 was $0.0 Mil.

Tactile Systems Technology DeferredTaxAndRevenue Related Terms

Tactile Systems Technology DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Tactile Systems Technology's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tactile Systems Technology DeferredTaxAndRevenue Chart

Tactile Systems Technology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Tactile Systems Technology Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TCMD
74GF Score
Tactile Systems Technology Inc TCMD
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of $0.0 Mil mean?
Tactile Systems Technology (TCMD) has a DeferredTaxAndRevenue of $0.0 Mil as of Mar. 2026. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Tactile Systems Technology.
Is Tactile Systems Technology's DeferredTaxAndRevenue too high?
Tactile Systems Technology's current DeferredTaxAndRevenue is $0.0 Mil. Overall, Tactile Systems Technology has a GF Score™ of 74/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tactile Systems Technology's DeferredTaxAndRevenue compare to SSII and BVS?
Tactile Systems Technology's DeferredTaxAndRevenue of $0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Medical Devices & Instruments company?
A good DeferredTaxAndRevenue depends on the Medical Devices & Instruments industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Tactile Systems Technology. Tactile Systems Technology's current DeferredTaxAndRevenue is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tactile Systems Technology stock overvalued right now?
Based on GuruFocus' analysis, Tactile Systems Technology (TCMD) is currently considered Significantly Overvalued. The stock's GF Value™ is $18.74, compared to a current price of $29.85 — trading 59.3% above its estimated fair value. The current DeferredTaxAndRevenue is $0.0 Mil. Tactile Systems Technology's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Tactile Systems Technology (TCMD), the current DeferredTaxAndRevenue is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tactile Systems Technology (TCMD) Overvalued in 2026?

Based on GuruFocus' analysis, Tactile Systems Technology stock appears to be overvalued. The current stock price of $29.85 is trading 59.3% above its estimated GF Value™ of $18.74. GuruFocus considers Tactile Systems Technology to be Significantly Overvalued.

Key valuation signals for TCMD:

  • DeferredTaxAndRevenue: $0.0 Mil
  • GF Value™: $18.74 vs. price of $29.85 (59.3% above fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the TCMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tactile Systems Technology Business Description

Other Exchanges 3L3:Germany
Address 3701 Wayzata Boulevard, Suite 300, Minneapolis, MN, USA, 55416
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
74GF Score

Get the complete analysis for TCMD

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$29.85
Price
$18.74
GF Value